Narcotic use and total hip arthroplasty

Background: The purpose of this study is to: (1) characterise risk factors for prolonged narcotic use following total hip arthroplasty (THA); (2) examine preoperative and prolonged postoperative narcotic use as independent risk factors for complications following THA. Methods: A national database identified primary THA patients from 2007–2015. Preoperative (POU) and prolonged postoperative narcotics users (PPU) were identified. A multivariable logistic regression analysis was utilised to identify any patient-related risk factors for prolonged use, and examined POU and PPU as risk factors for complications following THA. Results: 55,354 THA patients were included, 18,740 (33.8%) POU and 14,996 (27.1%) PPU. Preoperative narcotics use was the most significant factor associated with prolonged postoperative narcotic use. Preoperative and prolonged postoperative use were associated with significantly higher complications postoperatively. Conclusions: Preoperative narcotic use is the most significant patient specific risk factor for prolonged postoperative narcotic use. POUs and PPUs are at a significantly higher risk of postoperative infection and revision surgery.

[1]  J. Cancienne,et al.  Narcotic Use and Total Knee Arthroplasty. , 2018, The Journal of arthroplasty.

[2]  Gwo-Chin Lee,et al.  Preoperative Opiate Use Independently Predicts Narcotic Consumption and Complications After Total Joint Arthroplasty. , 2017, The Journal of arthroplasty.

[3]  J. Callaghan,et al.  Opioid Use Following Total Hip Arthroplasty: Trends and Risk Factors for Prolonged Use. , 2017, The Journal of arthroplasty.

[4]  B. Wolf,et al.  Opioid Consumption After Rotator Cuff Repair. , 2017, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[5]  R. Bonnie,et al.  Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use , 2017 .

[6]  D. Markel,et al.  Preoperative and Postoperative Opiate Use by the Arthroplasty Patient. , 2016, The Journal of arthroplasty.

[7]  Stephanie E. Moser,et al.  Trends and predictors of opioid use after total knee and total hip arthroplasty , 2016, Pain.

[8]  E. Roughead,et al.  Postoperative opioid use as an early indication of total hip arthroplasty failure , 2016, Acta orthopaedica.

[9]  E. Roughead,et al.  Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study , 2016, BMJ Open.

[10]  E. Roughead,et al.  Opioid use after total hip arthroplasty surgery is associated with revision surgery , 2016, BMC Musculoskeletal Disorders.

[11]  M. Whitehouse,et al.  Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis , 2016, PloS one.

[12]  M. V. D. van den Bekerom,et al.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts. , 2014, World journal of orthopedics.

[13]  Michael A. Mont,et al.  Opioid use prior to total hip arthroplasty leads to worse clinical outcomes , 2014, International Orthopaedics.

[14]  Robin L Bliss,et al.  Risk factors for revision of primary total hip arthroplasty: a systematic review , 2012, BMC Musculoskeletal Disorders.

[15]  Grant T. Baldwin,et al.  CDC grand rounds , 2012 .

[16]  Christopher M. Jones,et al.  CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic , 2012 .

[17]  C. Rutter,et al.  Trends in long‐term opioid therapy for chronic non‐cancer pain , 2009, Pharmacoepidemiology and drug safety.